Lisata Therapeutics (8NE.F) Q3 2024 Earnings

12AugConfirmed
Q2 2024
Q3 2024
-0.69
-0.64
-0.6
-0.56

Details

Expected EPS
-0.6858150000000001
Actual EPS
-0.5577962
Surprise EPS
0.13
Surprise Percent
+18.67%

Description

Lisata Therapeutics (8NE.F) has reported earnings of -0.5577962 per share for Q3 2024.

0 Comments

Share your thoughts